Kymera Therapeutics(KYMR) - 2025 Q4 - Earnings Call Presentation

Fourth Quarter & Full Year 2025 Quarterly Results Call February 26, 2026 Agenda Introduction Justine Koenigsberg, Vice President, Investor Relations Key Highlights and Business Update Nello Mainolfi, PhD, Founder, President and Chief Executive Officer Clinical Update Jared Gollob, MD, Chief Medical Officer Financial Review Bruce Jacobs, CFA, MBA, Chief Financial Officer Question and Answer Session Forward Looking Statements This presentation contains forward-looking statements within the meaning ofthe Priva ...